Mark A. Longer

571 total citations
10 papers, 468 citations indexed

About

Mark A. Longer is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Mark A. Longer has authored 10 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in Mark A. Longer's work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Pharmaceutical studies and practices (3 papers). Mark A. Longer is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Pharmaceutical studies and practices (3 papers). Mark A. Longer collaborates with scholars based in United States, Australia and United Kingdom. Mark A. Longer's co-authors include Joseph R. Robinson, Peter J. Gruber, M. Veillard, Thomas W. Martens, Praveen Tyle, Bhasker V. Shetty, John W. Mauger, Ian G. Tucker, Martin E. Dowty and John F. Woodley and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Annals of the New York Academy of Sciences.

In The Last Decade

Mark A. Longer

10 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Longer United States 9 316 104 44 39 35 10 468
K.J. Palin United Kingdom 12 323 1.0× 202 1.9× 71 1.6× 59 1.5× 69 2.0× 22 737
Rahul Vats India 10 237 0.8× 124 1.2× 34 0.8× 86 2.2× 40 1.1× 20 468
Sam T. Mathew India 12 264 0.8× 59 0.6× 19 0.4× 50 1.3× 19 0.5× 35 486
Seh Hyon Song South Korea 12 314 1.0× 75 0.7× 29 0.7× 54 1.4× 34 1.0× 16 447
Armand Michoel Belgium 10 244 0.8× 89 0.9× 13 0.3× 28 0.7× 19 0.5× 21 483
David A. Parkins United Kingdom 9 180 0.6× 36 0.3× 16 0.4× 46 1.2× 14 0.4× 13 389
Saeed Rezaee Iran 12 70 0.2× 81 0.8× 46 1.0× 77 2.0× 39 1.1× 43 433
Sam Corveleyn Belgium 11 204 0.6× 141 1.4× 14 0.3× 18 0.5× 13 0.4× 18 491
Kirk A. Overhoff United States 9 321 1.0× 80 0.8× 19 0.4× 35 0.9× 17 0.5× 10 472
Jong Hyuck Park South Korea 9 351 1.1× 102 1.0× 20 0.5× 82 2.1× 33 0.9× 9 505

Countries citing papers authored by Mark A. Longer

Since Specialization
Citations

This map shows the geographic impact of Mark A. Longer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Longer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Longer more than expected).

Fields of papers citing papers by Mark A. Longer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Longer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Longer. The network helps show where Mark A. Longer may publish in the future.

Co-authorship network of co-authors of Mark A. Longer

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Longer. A scholar is included among the top collaborators of Mark A. Longer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Longer. Mark A. Longer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Longer, Mark A., Praveen Tyle, & John W. Mauger. (1996). A Cubic-Phase Oral Drug Delivery System for Controlled Release of AG337. Drug Development and Industrial Pharmacy. 22(7). 603–608. 20 indexed citations
2.
Longer, Mark A., et al.. (1995). Preformulation Studies of a Novel HIV Protease Inhibitor, AG1343. Journal of Pharmaceutical Sciences. 84(9). 1090–1093. 35 indexed citations
3.
Longer, Mark A., et al.. (1995). Formulation development of an oral dosage form for an hiv protease inhibitor, AG1284. International Journal of Pharmaceutics. 117(2). 197–207. 2 indexed citations
4.
Kopečková, Pavla, Mark A. Longer, John F. Woodley, Ruth Duncan, & Jindřich Kopeček. (1991). Release of p‐nitroaniline from oligopeptide side chains attached to N‐(2‐hydroxypropyl)methacrylamide copolymers during incubation with rat intestinal brush border enzymes. Die Makromolekulare Chemie Rapid Communications. 12(2). 101–106. 10 indexed citations
5.
Tucker, Ian G., Martin E. Dowty, M. Veillard, Mark A. Longer, & Joseph R. Robinson. (1989). Reversed-Phase High-Performance Liquid Chromatographic Analysis of Oligoglycines (One to Six Amino Acid Residues). Pharmaceutical Research. 6(1). 100–102. 10 indexed citations
6.
Gruber, Peter J., Mark A. Longer, & Joseph R. Robinson. (1988). Some biological issues in oral, controlled drug delivery. Advanced Drug Delivery Reviews. 1(3). 268–268. 66 indexed citations
7.
Robinson, Joseph R., Mark A. Longer, & M. Veillard. (1987). Bioadhesive Polymers for Controlled Drug Delivery. Annals of the New York Academy of Sciences. 507(1). 307–314. 36 indexed citations
8.
Gruber, Peter J., Mark A. Longer, & Joseph R. Robinson. (1987). Some biological issues in oral, controlled drug delivery. Advanced Drug Delivery Reviews. 1(1). 1–18. 79 indexed citations
9.
Veillard, M., Mark A. Longer, Thomas W. Martens, & Joseph R. Robinson. (1987). Preliminary studies of oral mucosal delivery of peptide drugs. Journal of Controlled Release. 6(1). 123–131. 63 indexed citations
10.
Longer, Mark A., et al.. (1985). Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery III: Oral Delivery of Chlorothiazide Using a Bioadhesive Polymer. Journal of Pharmaceutical Sciences. 74(4). 406–411. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026